Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy

被引：7

作者：

Othman, Tamer A. ^{[1
]}

Zhang, Jianying ^{[2
]}

Mei, Matthew ^{[1
]}

Stein, Anthony S. ^{[1
]}

Forman, Stephen J. ^{[1
]}

Marcucci, Guido ^{[1
]}

Pullarkat, Vinod ^{[1
]}

Aldoss, Ibrahim ^{[1
]}

机构：

[1] City Hope Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA

[2] City Hope Med Ctr, Dept Informat Sci, Duarte, CA USA

来源：

LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 14期

关键词：

D O I：

10.1080/10428194.2020.1808213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3532 / 3533

页数：2

共 6 条

[1]

Aldoss I, 2019, AM J HEMATOL, V94

[2] Venetoclax and hypomethylating agents inFLT3-mutated acute myeloid leukemia [J].

Aldoss, Ibrahim ;

Zhang, Jianying ;

Mei, Matthew ;

Al Malki, Monzr M. ;

Arslan, Shukaib ;

Ngo, Dat ;

Aribi, Ahmed ;

Ali, Haris ;

Sandhu, Karamjeet ;

Salhotra, Amandeep ;

Koller, Paul ;

Khaled, Samer ;

Artz, Andrew ;

Snyder, David ;

Nakamura, Ryotaro ;

Forman, Stephen J. ;

Stein, Anthony S. ;

Marcucci, Guido ;

Pullarkat, Vinod .

AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) :1193-1199

[3] Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia [J].

Aldoss, Ibrahim ;

Zhang, Jianying ;

Pillai, Raju ;

Shouse, Geoffrey ;

Sanchez, James F. ;

Mei, Matthew ;

Nakamura, Ryotaro ;

Stein, Anthony S. ;

Forman, Stephen J. ;

Marcucci, Guido ;

Pullarkat, Vinod .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) :E45-E48

[4]

Byrne M, 2020, AM J HEMATOL

[5]

DiNardo CD, 2019, BLOOD, V133

[6]

Döhner K, 2017, BLOOD, V130

← 1 →